SLC5A12 and Sepsis: Our findings revealed three novel low-frequency variants associated with reduced 28-day survival among sepsis patients: one in SAMD9 (the p.Ala1556Thr exonic variant), one intergenic to SLC5A12\FIBIN, and another intergenic to LINC00378\MIR3169.